Category: N-Methyl-D-Aspartate Receptors
Trametinib is a MEK inhibitor approved both seeing that a single agent and in combination with dabrafenib for the treatment of V600E or V600K mutated melanoma
Trametinib is a MEK inhibitor approved both seeing that a single agent and in combination with dabrafenib for the treatment of V600E or V600K mutated melanoma. cancers, but the majority of skin can... Read MoreSupplementary MaterialsAdditional file 1: Table S1A
Supplementary MaterialsAdditional file 1: Table S1A. from 10?L of undiluted plasma from dairy cows and the detection limit of the assay was 0.4?ng/mL. The intra- and inter-assay coefficients of var... Read More- 2 of 2
- « Previous
- 1
- 2